Vanguard Group Inc Aquestive Therapeutics, Inc. Put Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AQST
# of Institutions
105Shares Held
42.1MCall Options Held
463KPut Options Held
431K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$25.5 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY5.56MShares$14.4 Million2.03% of portfolio
-
Franklin Resources Inc San Mateo, CA2.22MShares$5.77 Million0.0% of portfolio
-
Laurion Capital Management LP New York, NY1.55MShares$4.02 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.38MShares$3.58 Million0.01% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $139M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...